Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity

Insulin-like growth factor-1 (IGF-1) and its binding proteins and receptors are widely expressed in the central nervous system (CNS), proposing IGF-1-induced neurotrophic actions in normal growth, development, and maintenance. However, while there is convincing evidence that the IGF-1 system has spe...

Full description

Bibliographic Details
Main Authors: Lijun Ge, Shuyuan Liu, Limor Rubin, Philip Lazarovici, Wenhua Zheng
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/4/666
_version_ 1827656311005773824
author Lijun Ge
Shuyuan Liu
Limor Rubin
Philip Lazarovici
Wenhua Zheng
author_facet Lijun Ge
Shuyuan Liu
Limor Rubin
Philip Lazarovici
Wenhua Zheng
author_sort Lijun Ge
collection DOAJ
description Insulin-like growth factor-1 (IGF-1) and its binding proteins and receptors are widely expressed in the central nervous system (CNS), proposing IGF-1-induced neurotrophic actions in normal growth, development, and maintenance. However, while there is convincing evidence that the IGF-1 system has specific endocrine roles in the CNS, the concept is emerging that IGF-I might be also important in disorders such as ischemic stroke, brain trauma, Alzheimer’s disease, epilepsy, etc., by inducing neuroprotective effects towards glutamate-mediated excitotoxic signaling pathways. Research in rodent models has demonstrated rescue of pathophysiological and behavioral abnormalities when IGF-1 was administered by different routes, and several clinical studies have shown safety and promise of efficacy in neurological disorders of the CNS. Focusing on the relationship between IGF-1-induced neuroprotection and glutamate-induced excitatory neurotoxicity, this review addresses the research progress in the field, intending to provide a rationale for using IGF-I clinically to confer neuroprotective therapy towards neurological diseases with glutamate excitotoxicity as a common pathological pathway.
first_indexed 2024-03-09T22:19:50Z
format Article
id doaj.art-0efbeeda4d5b4acb93b3e54393f4a6db
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T22:19:50Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-0efbeeda4d5b4acb93b3e54393f4a6db2023-11-23T19:15:01ZengMDPI AGCells2073-44092022-02-0111466610.3390/cells11040666Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced NeurotoxicityLijun Ge0Shuyuan Liu1Limor Rubin2Philip Lazarovici3Wenhua Zheng4Center of Reproduction, Development and Aging Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, ChinaCollege of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, ChinaAllergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem 9112001, IsraelPharmacology, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, IsraelCenter of Reproduction, Development and Aging Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, ChinaInsulin-like growth factor-1 (IGF-1) and its binding proteins and receptors are widely expressed in the central nervous system (CNS), proposing IGF-1-induced neurotrophic actions in normal growth, development, and maintenance. However, while there is convincing evidence that the IGF-1 system has specific endocrine roles in the CNS, the concept is emerging that IGF-I might be also important in disorders such as ischemic stroke, brain trauma, Alzheimer’s disease, epilepsy, etc., by inducing neuroprotective effects towards glutamate-mediated excitotoxic signaling pathways. Research in rodent models has demonstrated rescue of pathophysiological and behavioral abnormalities when IGF-1 was administered by different routes, and several clinical studies have shown safety and promise of efficacy in neurological disorders of the CNS. Focusing on the relationship between IGF-1-induced neuroprotection and glutamate-induced excitatory neurotoxicity, this review addresses the research progress in the field, intending to provide a rationale for using IGF-I clinically to confer neuroprotective therapy towards neurological diseases with glutamate excitotoxicity as a common pathological pathway.https://www.mdpi.com/2073-4409/11/4/666glutamate-mediated excitotoxicitysignaling pathwaysinsulin-like growth factor-1neuroprotectionanimal modelsclinical trials
spellingShingle Lijun Ge
Shuyuan Liu
Limor Rubin
Philip Lazarovici
Wenhua Zheng
Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
Cells
glutamate-mediated excitotoxicity
signaling pathways
insulin-like growth factor-1
neuroprotection
animal models
clinical trials
title Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
title_full Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
title_fullStr Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
title_full_unstemmed Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
title_short Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
title_sort research progress on neuroprotection of insulin like growth factor 1 towards glutamate induced neurotoxicity
topic glutamate-mediated excitotoxicity
signaling pathways
insulin-like growth factor-1
neuroprotection
animal models
clinical trials
url https://www.mdpi.com/2073-4409/11/4/666
work_keys_str_mv AT lijunge researchprogressonneuroprotectionofinsulinlikegrowthfactor1towardsglutamateinducedneurotoxicity
AT shuyuanliu researchprogressonneuroprotectionofinsulinlikegrowthfactor1towardsglutamateinducedneurotoxicity
AT limorrubin researchprogressonneuroprotectionofinsulinlikegrowthfactor1towardsglutamateinducedneurotoxicity
AT philiplazarovici researchprogressonneuroprotectionofinsulinlikegrowthfactor1towardsglutamateinducedneurotoxicity
AT wenhuazheng researchprogressonneuroprotectionofinsulinlikegrowthfactor1towardsglutamateinducedneurotoxicity